The consistent provision of guideline-directed medical therapy (GDMT) — care delivered according to established guidelines and safety standards — is crucial for every healthcare encounter, especially when treating patients with chronic disease. Chronic diseases are “among the most common, costly, and preventable of all health problems,” according to the Centers for Disease Control (CDC).[1] About half of all U.S. adults suffer from one or more chronic diseases, and 86 percent of the United States’ $2.7 trillion annual healthcare expenditures are the result of chronic illness.

Supraventricular tachycardia (SVT) is a common heart abnormality that presents as a fast heart rate. SVT is a generic term applied to any tachycardia originating above the ventricles and which involves atrial tissue or atrioventricular (AV) nodal tissue4. This heart rhythm disturbance can occur in healthy individuals and may include such symptoms as chest pain, palpitations, shortness of breath, sweating, feeling faint, and, rarely, unconsciousness may occur. The incidence of SVT is approximately 35 cases per 100,000 patients with a prevalence of 2.25 cases per 1,000 in the general population2.